dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Feliciano Aguirre, Andrea F |
dc.contributor.author | Gonzalez Amaya, Lucila |
dc.contributor.author | Garcia Mayea, Yoelsis |
dc.contributor.author | Mir Perez, Cristina |
dc.contributor.author | Artola, Mireia |
dc.contributor.author | Barragán, Nieves |
dc.contributor.author | Castellví Vives, Josep |
dc.contributor.author | Benavente Norza, Sergio |
dc.contributor.author | Ramon y Cajal Agüeras, Santiago |
dc.contributor.author | Espinosa Bravo, Martin |
dc.contributor.author | Cortés Castan, Javier |
dc.contributor.author | Lleonart Pajarin, Matilde |
dc.date.accessioned | 2021-09-09T10:54:26Z |
dc.date.available | 2021-09-09T10:54:26Z |
dc.date.issued | 2020-11-03 |
dc.identifier.citation | Feliciano A, González L, Garcia-Mayea Y, Mir C, Artola M, Barragán N, et al. Five microRNAs in Serum Are Able to Differentiate Breast Cancer Patients From Healthy Individuals. Front Oncol. 2020 Nov 3;10:586268. |
dc.identifier.issn | 2234-943X |
dc.identifier.uri | https://hdl.handle.net/11351/6288 |
dc.description | Càncer de mama; Diagnòstic; Sèrum |
dc.description.sponsorship | This work was supported by ISCIII (Instituto de Salud Carlos III) Ref. FIS PI15/01262, co-financed by the European Regional Development Fund (ERDF) and AECC Project GEC Ref. GC16173720CARR (ML). AF, YG-M, and CM were granted with P-FIS, VHIR, and iP-FIS fellowships, respectively. |
dc.language.iso | eng |
dc.publisher | Frontiers Media |
dc.relation.ispartofseries | Frontiers in Oncology;10 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | MicroARN |
dc.subject | Mama - Càncer - Diagnòstic |
dc.subject.mesh | Breast Neoplasms |
dc.subject.mesh | Circulating MicroRNA |
dc.subject.mesh | /diagnosis |
dc.title | Five microRNAs in Serum Are Able to Differentiate Breast Cancer Patients From Healthy Individuals |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.3389/fonc.2020.586268 |
dc.subject.decs | neoplasias de la mama |
dc.subject.decs | microARN circulante |
dc.subject.decs | /diagnóstico |
dc.relation.publishversion | https://doi.org/10.3389/fonc.2020.586268 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Feliciano A, González L, Garcia-Mayea Y, Mir C, Castellvi J, Benavente S, Ramón Y Cajal S] Grup de Recerca biomèdica amb cel·lules mare del càncer, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Artola M, Barragán N] Primary Care Center CAP-Vallcarca-Sant Gervasi, Barcelona, Spain. [Espinosa-Bravo M] Unitat de Patologia Mamària, Vall d'Hebron Hospital Universitari, Barcelona, Spain. [Cortés J] Institute of Breast Cancer, Quiron Group, Barcelona, Spain. Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. [LLeonart ME] Grup de Recerca biomèdica amb cel·lules mare del càncer, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Spanish Biomedical Research Network Center in Oncology, Madrid, Spain |
dc.identifier.pmid | 33224883 |
dc.identifier.wos | 000589958800001 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/PI15%2F01262 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |